Nutrien (NTR) Stock Forecast & Price Target

$47.22 -0.96 (-1.99%)

(As of 01:28 PM ET)

Nutrien - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 18 Analyst Ratings

Sell
3

Hold
4

Buy
11

Based on 18 Wall Street analysts who have issued ratings for Nutrien in the last 12 months, the stock has a consensus rating of "Hold." Out of the 18 analysts, 3 have given a sell rating, 4 have given a hold rating, and 11 have given a buy rating for NTR.

Consensus Price Target

$58.95
24.84% Upside

According to the 18 analysts' twelve-month price targets for Nutrien, the average price target is $58.95. The highest price target for NTR is $75.00, while the lowest price target for NTR is $48.00. The average price target represents a forecasted upside of 24.84% from the current price of $47.22.

Get the Latest News and Ratings for NTR and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Nutrien and its competitors.

NTR Analyst Ratings Over Time

Type	Current Forecast 12/17/23 to 12/16/24	1 Month Ago 11/17/23 to 11/16/24	3 Months Ago 9/18/23 to 9/17/24	1 Year Ago 12/17/22 to 12/17/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	11 Buy rating(s)	10 Buy rating(s)	12 Buy rating(s)	10 Buy rating(s)
Hold	4 Hold rating(s)	6 Hold rating(s)	4 Hold rating(s)	8 Hold rating(s)
Sell	3 Sell rating(s)	3 Sell rating(s)	3 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$58.95	$60.33	$62.39	$77.65
Forecasted Upside	24.84% Upside	30.62% Upside	32.97% Upside	41.46% Upside
Consensus Rating	Hold	Hold	Hold	Hold

URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

The crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most explosive phase of the cycle.

>> Register for the Free WaveBot Workshop Now

NTR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

NTR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Nutrien Stock vs. The Competition

Type	Nutrien	Basic Materials Companies	S&P 500
Consensus Rating Score	2.44	2.76	2.51
Consensus Rating	Hold	Moderate Buy	Moderate Buy
Predicted Upside	22.35% Upside	134.75% Upside	10.61% Upside
News Sentiment Rating	Positive News See Recent NTR News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
12/12/2024	Oppenheimer 3 of 5 stars		Initiated Coverage	Outperform	$60.00	+25.31%
12/10/2024	CIBC 3 of 5 stars		Reiterated Rating	Outperformer	$60.00 ➝ $55.00	+12.45%
12/3/2024	Raymond James 4 of 5 stars	S. Hansen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Market Perform ➝ Outperform	$58.00 ➝ $60.00	+25.63%
11/12/2024	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy	$63.00 ➝ $61.00	+29.32%
10/10/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Spector Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$66.00 ➝ $51.00	+4.04%
9/24/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Garchitorena Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Overweight ➝ Equal Weight	$62.00 ➝ $50.00	+5.31%
Get the Latest News and Ratings for NTR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Nutrien and its competitors with MarketBeat's FREE daily newsletter.
9/20/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$60.00 ➝ $60.00	+25.26%
9/10/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Samuelson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$69.00 ➝ $53.00	+14.99%
8/16/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$68.00 ➝ $55.00	+18.69%
8/12/2024	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Sector Outperform ➝ Sector Outperform	$66.00 ➝ $59.00	+26.96%
8/9/2024	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform ➝ Outperform	$80.00 ➝ $75.00	+63.58%
8/8/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	E. Rodriguez Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Neutral ➝ Neutral	$55.00 ➝ $52.00	+14.66%
8/2/2024	Hsbc Global Res Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Seshadri Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Hold ➝ Moderate Sell
8/2/2024	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Hold ➝ Reduce
6/11/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Underweight ➝ Underweight	$56.00 ➝ $55.00	+3.33%
4/29/2024	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy	$60.00 ➝ $66.00	+25.59%
3/26/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$62.00	+17.92%
3/1/2024	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$66.00	+26.36%
2/23/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Neutral ➝ Underweight	$58.00 ➝ $48.00	-11.36%
1/19/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$72.00 ➝ $75.00	+49.31%
11/30/2023	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Neutral
7/25/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Equal Weight ➝ Equal Weight	$70.00	+5.69%
6/8/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$94.00 ➝ $85.00	+44.73%
5/11/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$70.00 ➝ $60.00	-5.30%
3/28/2023	Erste Group Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Hold
1/20/2023	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy	$87.00 ➝ $86.00	+12.82%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 01:47 PM ET.

Should I Buy Nutrien Stock? NTR Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, December 12, 2024. Please send any questions or comments about these Nutrien pros and cons to contact@marketbeat.com.

Nutrien
Bull Case

Here are some ways that investors could benefit from investing in Nutrien Ltd.:

Nutrien Ltd. recently increased its quarterly dividend from $0.54 to $0.939 per share, reflecting a strong commitment to returning value to shareholders. This increase represents an annualized yield of 8.05%, which is attractive for income-focused investors.
The company has a solid market capitalization of approximately $23.67 billion, indicating a stable financial position and the ability to invest in growth opportunities.
Despite recent downgrades from several analysts, Nutrien Ltd. has received a consensus rating of "Hold" with a price target around $60.06, suggesting potential for price appreciation from its current trading price of $47.93.
Nutrien Ltd. operates through multiple segments, including Retail, Potash, Nitrogen, and Phosphate, which diversifies its revenue streams and reduces dependency on any single market segment.
The company reported a revenue of $5.35 billion in its latest quarter, exceeding analysts' expectations, which indicates strong operational performance and demand for its products.

Nutrien
Bear Case

Investors should be bearish about investing in Nutrien Ltd. for these reasons:

Nutrien Ltd. has experienced a decline in its stock price, which has dropped from a 1-year high of $60.87 to its current price of $47.93, indicating potential volatility and investor uncertainty.
The company reported a year-over-year revenue decrease of 5.0%, which may signal challenges in maintaining growth and could affect future earnings.
Analysts have issued multiple downgrades, with firms like UBS and Goldman Sachs reducing their price targets significantly, which may reflect a bearish outlook on the company's future performance.
The dividend payout ratio is notably high at 144.97%, suggesting that the company is paying out more in dividends than it is earning, which could be unsustainable in the long term.
With 63.10% of the stock owned by hedge funds and institutional investors, there may be less stability in the stock price due to potential large sell-offs by these entities.

NTR Forecast - Frequently Asked Questions

: According to the research reports of 18 Wall Street equities research analysts, the average twelve-month stock price forecast for Nutrien is $58.95, with a high forecast of $75.00 and a low forecast of $48.00.
: 18 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Nutrien in the last year. There are currently 3 sell ratings, 4 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" NTR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NTR, but not buy additional shares or sell existing shares.
: According to analysts, Nutrien's stock has a predicted upside of 24.84% based on their 12-month stock forecasts.
: Over the previous 90 days, Nutrien's stock had 2 downgrades and 1 upgrade by analysts.
: Nutrien has been rated by research analysts at CIBC, Oppenheimer, Raymond James, Royal Bank of Canada, TD Securities, UBS Group, and Wells Fargo & Company in the past 90 days.
: Analysts like Nutrien less than other "basic materials" companies. The consensus rating for Nutrien is Hold while the average consensus rating for "basic materials" companies is Moderate Buy. Learn more on how NTR compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

It’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life-changing for those who are prepared. Why? Because altcoin prices are about to explode.

>> Register for the Workshop Now

This page (NYSE:NTR) was last updated on 12/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Nutrien (NTR) Stock Forecast & Price Target